A Phase 4 interventional study of High-flow medical oxygen insufflation and Low-flow medical oxygen insufflation in Hypoxemia During Surgery, sponsored by Outcomes'10. Enrolling by invitation at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by Outcomes'10 · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Hypoxia with a site in Spain — 11 open to participants now, 11 under way, 5 of them phase 3. Hypoxia · Spain.
Among the 31 studies in Hypoxia with a site in Spain, this one is the 2nd largest by planned enrollment of the 25 interventional ones that give a count, is one of 2 that started in 2026, is the only one in phase 4, reaches primary completion later than 7 of the 10 other live ones, and was the 29th registered.
1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.
Browse Hypoxia studies →11 of the 31 studies in Hypoxia with a site in Spain are open now. Recruiting first, the newest first:
Jesús Manuel Nieves Alonso · Sites in Spain
Ages 18+
Iconic Solutions By Murcia SL · Sites in Spain
Ages 18+
Copenhagen Trial Unit, Center for Clinical Intervention Research · Sites in Spain
Ages 0 days–28 days
Universidad Rey Juan Carlos · Sites in Spain
Ages 18–65 · Healthy volunteers
Universidad Rey Juan Carlos · Sites in Spain
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 124 Hypoxia studies recruiting now, 52 (42%) set no upper age limit and 46 (37%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 326 is above the median of 45 across 771 interventional studies indexed under Hypoxia.
Median enrollment 60 across the 25 interventional studies, 150 across the 5 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 31 have an industry lead sponsor. The 10 most frequent:
Outcomes'10 is the lead sponsor of 7 studies on the registry; 4 are open to participants now.
Outcomes'10 has 1 study filed under Hypoxia — fewer than ten, so there is no comparison to draw.
1 of the studies in Hypoxia with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07432191Iconic Solutions By Murcia SLMedical Device Clinical Trial Without CE Marking to Evidence Safety and Performance of the INBENTUS VERSATILE Ventilator in Patients Requiring Assisted/Controlled Mechanical Ventilation and Weaning. | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 31 studies in Hypoxia with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study investigates the use of high-flow oxygen therapy devices in patients at higher risk of complications during sedated digestive endoscopies. Sedation controlled by the endoscopist improves patient tolerance and facilitates higher-quality procedures, but it can have side effects such as hypoxemia or respiratory depression, especially in patients with sleep apnea, obesity, lung diseases, those over 60 years old, or with a history of sedation complications. While preventive measures, such as oxygen administration, are taken, the study aims to compare the effectiveness of new high-flow oxygen therapy devices with conventional nasal cannulas to improve safety during endoscopies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Low-flow medical oxygen insufflation
Drug: Low-flow medical oxygen insufflation
High-flow medical oxygen insufflation
Drug: High-flow medical oxygen insufflation
High-flow medical oxygen insufflation
Low-flow medical oxygen insufflation
Number of episodes of hypoxemia
The number of hypoxemia episodes per procedure
Time frame: Periprocedural
Severity of episode of hypoxemia pO2 value
Severity of episode of hypoxemia (pO2 90- 80%) - (pO2 \<80%)
Time frame: Periprocedural
Duration of episode of hypoxemia (in seconds)
Duration of episode of hypoxemia (in seconds)
Time frame: Periprocedural
Sex (Demographic and explanatory factors)
Sex (Demographic and explanatory factors)
Time frame: Periprocedural
Age (Demographic and explanatory factors)
Age (Demographic and explanatory factors)
Time frame: Periprocedural
Body mass index (Demographic and explanatory factors)
Body mass index (Demographic and explanatory factors)
Time frame: Periprocedural
Demographic and explanatory factors
anesthetic risk classification: ASA physical status classification Obstructive Sleep Apnea (OSA) or suspected OSA based on the STOP-Bang questionnaire Chronic respiratory disease Chronic heart disease Chronic use of sedative medications History of prior respiratory complication during an endoscopic sedation procedure (ESP)
Time frame: Periprocedural
Medical History Demographic and explanatory factors
Medical History Demographic and explanatory factors
Time frame: Periprocedural
Type of Medication and treatment used (Demographic and explanatory factors)
Type of Medication and treatment used (Demographic and explanatory factors)
Time frame: Periprocedural
Demographic and explanatory factors
Duration of diagnostic/ therapeutic endoscopic Procedure
Time frame: Periprocedural
Variable results
value of baseline pO2
Time frame: Periprocedural
Variable results
Complications and Clinical Events
Time frame: Periprocedural
Length of stay at recovery room and post-procedure (Variable results)
Length of stay at recovery room and post-procedure
Time frame: Periprocedural
pO2 value (Variable results)
lowest pO2 value during the procedure
Time frame: Periprocedural
Plan to share: No — Individual participant data will not be shared. The data will be pseudonymized to ensure privacy and will only be accessible to the research team directly involved in the study.
No publications or documents are linked to this record.
Start is estimated for Mar 2026; primary completion for Oct 2026, 7 months later.
Of 17 phase 4 interventional studies under Hypoxia, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 7 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Outcomes'10